Performance of the Disc Diffusion Method, MTS Gradient Tests and Two Commercially Available Microdilution Tests for the Determination of Cefiderocol Susceptibility in <i>Acinetobacter</i> spp.
Cefiderocol is a siderophore-conjugated cephalosporin with potent activity against multidrug-resistant Gram-negative pathogens including <i>Acinetobacter baumannii</i>. The aim of this study was to evaluate cefiderocol testing methods on a relevant collection of 97 <i>Acinetobacter...
Main Authors: | Katy Jeannot, Susie Gaillot, Pauline Triponney, Sylvain Portets, Valentin Pourchet, Damien Fournier, Anaïs Potron |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Microorganisms |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2607/11/8/1971 |
Similar Items
-
Genomic characterization of an NDM-9-producing Acinetobacter baumannii clinical isolate and role of Glu152Lys substitution in the enhanced cefiderocol hydrolysis of NDM-9
by: Susie Gaillot, et al.
Published: (2023-08-01) -
Comparison of Disk Diffusion, E-Test, and Broth Microdilution Methods for Testing In Vitro Activity of Cefiderocol in <i>Acinetobacter baumannii</i>
by: Natalia Kolesnik-Goldmann, et al.
Published: (2023-07-01) -
Human Serum Proteins and Susceptibility of <i>Acinetobacter baumannii</i> to Cefiderocol: Role of Iron Transport
by: Casin Le, et al.
Published: (2022-03-01) -
Assessment of cefiderocol disk diffusion versus broth microdilution results when tested against Acinetobacter baumannii complex clinical isolates
by: Yanling Liu, et al.
Published: (2023-12-01) -
Assessment of In Vitro Cefiderocol Susceptibility and Comparators against an Epidemiologically Diverse Collection of <i>Acinetobacter baumannii</i> Clinical Isolates
by: Clara Ballesté-Delpierre, et al.
Published: (2022-01-01)